BR100 Increased By (0.64%)
BR30 Increased By (0.91%)
KSE100 Increased By (0.45%)
KSE30 Increased By (0.46%)
BECO 6.02 Increased By ▲ 0.25 (4.33%)
BML 52.60 Decreased By ▼ -0.40 (-0.75%)
BOP 34.35 Increased By ▲ 0.36 (1.06%)
CNERGY 8.12 Increased By ▲ 0.01 (0.12%)
DCL 12.06 Decreased By ▼ -0.14 (-1.15%)
FCCL 53.42 Increased By ▲ 0.59 (1.12%)
FCSC 5.20 Increased By ▲ 0.13 (2.56%)
FFL 18.02 Increased By ▲ 0.07 (0.39%)
FNEL 1.32 Increased By ▲ 0.03 (2.33%)
HUMNL 10.88 No Change ▼ 0.00 (0%)
KEL 8.09 Increased By ▲ 0.07 (0.87%)
KOSM 5.44 Decreased By ▼ -0.08 (-1.45%)
MLCF 87.35 Increased By ▲ 0.84 (0.97%)
NBP 186.99 Increased By ▲ 1.83 (0.99%)
PACE 10.68 Increased By ▲ 0.10 (0.95%)
PAEL 39.91 Increased By ▲ 0.49 (1.24%)
PIAHCLA 26.12 Decreased By ▼ -0.10 (-0.38%)
PIBTL 16.95 Increased By ▲ 0.28 (1.68%)
PPL 229.90 Increased By ▲ 1.72 (0.75%)
PRL 34.80 Increased By ▲ 0.12 (0.35%)
PTC 67.18 Increased By ▲ 1.85 (2.83%)
SEARL 90.80 Increased By ▲ 0.67 (0.74%)
SSGC 26.82 Increased By ▲ 0.22 (0.83%)
TELE 8.61 Increased By ▲ 0.33 (3.99%)
THCCL 58.69 Increased By ▲ 0.19 (0.32%)
TPLP 8.58 Increased By ▲ 0.36 (4.38%)
TREET 24.62 Increased By ▲ 0.09 (0.37%)
TRG 69.89 Increased By ▲ 0.18 (0.26%)
WAVES 10.09 Increased By ▲ 0.15 (1.51%)
WTL 1.30 Increased By ▲ 0.02 (1.56%)
World

EU says Pfizer/BioNTech to deliver 75 million extra vaccine doses in second quarter

  • "BioNTech/Pfizer will deliver 75 million of additional doses in the second quarter of the year - and up to 600 millions in total in 2021," von der Leyen wrote on Twitter.
Published February 1, 2021 Updated February 1, 2021 02:50pm
By

BRUSSELS Pfizer and German partner BioNTech will deliver 75 million extra doses of their COVID-19 vaccine in the second quarter of the year, European Commission President Ursula von der Leyen said on Monday.

"BioNTech/Pfizer will deliver 75 million of additional doses in the second quarter of the year - and up to 600 millions in total in 2021," von der Leyen wrote on Twitter.

The EU, whose member states are far behind Israel, Britain and the United States in rolling out vaccines, is scrambling to get supplies just as the West's biggest drugmakers slow deliveries to the bloc due to production problems.

Comments

Comments are closed for this article.